###begin article-title 0
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="author-notes" rid="fn1">1</xref>
###xml 109 110 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="author-notes" rid="fn1">1</xref></sup>
Hypothalamic neuronal histamine mediates the thyrotropin-releasing hormone-induced suppression of food intake1
###end article-title 0
###begin p 1
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
###end p 1
###begin p 2
###xml 290 291 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 220 223 <span type="species:ncbi:10116">rat</span>
###xml 453 457 <span type="species:ncbi:10116">rats</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10116">rats</span>
###xml 1330 1334 <span type="species:ncbi:10116">rats</span>
We examined the involvement of thyrotropin-releasing hormone (TRH) and TRH type 1 and 2 receptors (TRH-R1 and TRH-R2, respectively) in the regulation of hypothalamic neuronal histamine. Infusion of 100 nmol TRH into the rat third cerebroventricle (3vt) significantly decreased food intake (p < 0.05) compared to controls infused with phosphate- buffered saline. This TRH-induced suppression of food intake was attenuated partially in histamine-depleted rats pre-treated with alpha-fluoromethylhistidine (a specific suicide inhibitor of histidine decarboxylase) and in mice with targeted disruption of histamine H1 receptors. Infusion of TRH into the 3vt increased histamine turnover as assessed by pargyline-induced accumulation of tele-methylhistamine (t-MH, a major metabolite of neuronal histamine in the brain) in the tuberomammillary nucleus (TMN), the paraventricular nucleus, and the ventromedial hypothalamic nucleus in rats. In addition, TRH-induced decrease of food intake and increase of histamine turnover were in a dose-dependent manner. Microinfusion of TRH into the TMN increased t-MH content, histidine decarboxylase (HDC) activity and expression of HDC mRNA in the TMN. Immunohistochemical analysis revealed that TRH-R2, but not TRH-R1, was expressed within the cell bodies of histaminergic neurons in the TMN of rats. These results indicate that hypothalamic neuronal histamine mediates the TRH-induced suppression of feeding behavior.
###end p 2
###begin p 3
###xml 116 130 116 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">Yarbrough 1979</xref>
Thyrotropin-releasing hormone (TRH) plays a fundamental role in the regulation of anterior pituitary TSH secretion (Yarbrough 1979). The endocrine function of TRH is supported by TRH type 1 receptors (TRH-R1) that are localized predominantly to hypothalamic regions. In addition, TRH-R1 expressed in other regions, such as the brain stem and spinal cord support a functional link between TRH and vegetative and autonomic functions. In contrast to the expression of TRH-R1, TRH type 2 receptor (TRH-R2) mRNA is distributed widely throughout the brain, including the thalamus, cerebral and cerebellar cortex, and the reticular formation. This distribution of TRH-R2 indicates that TRH is involved in higher cognitive functions as well as in regulating the arousal system, locomotor activity, and pain perception.
###end p 3
###begin p 4
###xml 145 151 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 139 156 139 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Ahima <italic>et al.</italic> 1996</xref>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 158 177 158 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Legradi <italic>et al.</italic> 1997</xref>
###xml 179 203 179 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">Nillni and Sevarino 1999</xref>
###xml 305 333 305 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Flier and Maratos-Flier 1998</xref>
###xml 335 349 335 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">Mantzoros 1999</xref>
###xml 358 364 358 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 351 369 351 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">Nillni <italic>et al.</italic> 2000</xref>
###xml 685 691 685 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 679 696 679 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Vogel <italic>et al.</italic> 1979</xref>
###xml 698 720 698 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">Morley and Levine 1980</xref>
###xml 729 735 729 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 722 740 722 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Breese <italic>et al.</italic> 1981</xref>
It was suggested recently that leptin plays an important role in the neuroendocrine regulation of the hypothalamic-pituitary-thyroid axis (Ahima et al. 1996; Legradi et al. 1997; Nillni and Sevarino 1999). TRH gene expression in the paraventricular nucleus (PVN) has been shown to be regulated by leptin (Flier and Maratos-Flier 1998; Mantzoros 1999; Nillni et al. 2000). In addition, neurons in the PVN that release TRH express both leptin and melanocortin-4 receptors, which suggests that TRH is an important part of the signaling systems that regulate feeding behavior. In line with this hypothesis, acute central administration TRH was reported to have anorexigenic effects (Vogel et al. 1979; Morley and Levine 1980; Breese et al. 1981).
###end p 4
###begin p 5
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 120 135 120 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">Doi <italic>et al.</italic> 1994</xref>
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 137 155 137 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">Sakata <italic>et al.</italic> 1997</xref>
###xml 163 169 163 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 157 180 157 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11 b12">Huang <italic>et al.</italic> 2001, 2006</xref>
###xml 335 341 335 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 326 346 326 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Fukagawa <italic>et al.</italic> 1989</xref>
###xml 566 572 566 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 555 577 555 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">Yoshimatsu <italic>et al.</italic> 2001</xref>
###xml 897 903 893 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 917 923 913 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 910 928 906 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Masaki <italic>et al.</italic> 2001</xref>
###xml 1203 1209 1199 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1194 1214 1190 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">Elmquist <italic>et al.</italic> 1998</xref>
###xml 1291 1297 1287 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1283 1302 1279 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Legradi <italic>et al.</italic> 1997</xref>
###xml 1423 1429 1419 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1412 1434 1408 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">Airaksinen <italic>et al.</italic> 1992</xref>
###xml 640 644 <span type="species:ncbi:10116">rats</span>
###xml 817 821 <span type="species:ncbi:10090">mice</span>
###xml 879 883 <span type="species:ncbi:10090">mice</span>
###xml 910 916 <span type="species:ncbi:212708">Masaki</span>
Histamine is a neurotransmitter that regulates appetite, energy metabolism, body temperature, and the sleep-wake cycle (Doi et al. 1994; Sakata et al. 1997; Huang et al. 2001, 2006). We demonstrated previously that neuronal histamine suppressed food intake via H1 receptors within the PVN and ventromedial hypothalamus (VMH) (Fukagawa et al. 1989). Furthermore, hypothalamic neuronal histamine is one of the hypothalamic targets of leptin, as indicated by the observation that leptin accelerates the release of neuronal histamine within the hypothalamus (Yoshimatsu et al. 2001). Leptin-induced suppression of feeding is attenuated both in rats in which histamine has been depleted by alpha-fluoromethylhistidine (FMH), a suicide inhibitor of histamine synthesizing histidine decarboxylase (HDC) enzyme as well as in mice with targeted disruption of histamine H1 receptors (H1KO mice) (Yoshimatsu et al. 1998; Masaki et al. 2001). In contrast to the functional connection between histamine and leptin, little is known about how leptin activates neuronal histamine because the long form of the leptin receptor is not expressed by histaminergic neurons within the tuberomammillary nucleus (TMN) (Elmquist et al. 1998). As stated above, leptin elicits the expression of TRH in the PVN (Legradi et al. 1997). In addition, TRH immunoreactivity has been identified in some histamine-containing neurons within the TMN (Airaksinen et al. 1992). The aforementioned findings suggest that TRH might mediate leptin signaling to histaminergic neurons.
###end p 5
###begin p 6
In the present study, we examined the neuroanatomical and functional relationship between TRH and neuronal histamine. We tested whether histamine depletion and targeted disruption of histamine H1 receptors attenuated the anorexic effects of TRH, if TRH increased histamine turnover within hypothalamic nuclei that are involved in energy homeostasis, and whether TRH receptors were expressed in histaminergic neurons within the TMN.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
Animals
###end title 8
###begin p 9
###xml 227 233 227 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 221 238 221 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">Inoue <italic>et al.</italic> 1996</xref>
###xml 296 298 296 298 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">am</sc>
###xml 304 306 304 306 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pm</sc>
###xml 621 632 611 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Sakata 1982</xref>
###xml 31 50 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 446 449 <span type="species:ncbi:10116">rat</span>
###xml 507 511 <span type="species:ncbi:10116">rats</span>
We used adult (250-280 g) male Sprague-Dawley rats (Seac Yoshitomi, Fukuoka, Japan), and adult (25-30 g) male H1KO mice (C57BL/6 background). H1KO mice were generated by homogeneous recombination as described previously (Inoue et al. 1996). Animals were housed in a room illuminated daily from 7 am to 7 pm (12 h light-dark cycle) at a temperature of 21 +/- 1degreesC and 55 +/- 5% relative humidity. Animals were allowed free access to standard rat chow (CE-2; Clea Japan, Tokyo, Japan) and tap water. All rats were handled for 5 min on four successive days prior to each experiment to equilibrate the level of arousal (Sakata 1982). All studies were conducted in accordance with Oita University Guidelines for Animal Care, which are based on the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
###end p 9
###begin title 10
Surgery
###end title 10
###begin p 11
###xml 686 709 686 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Paxinos and Watson 1986</xref>
###xml 1011 1036 1011 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">Franklin and Paxinos 1997</xref>
###xml 1128 1134 1128 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1121 1139 1121 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">Sakata <italic>et al.</italic> 1981</xref>
###xml 56 60 <span type="species:ncbi:10116">rats</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
Under anesthesia (50 mg/kg sodium pentobarbital, i.p.), rats were placed in a stereotaxic apparatus (Narishige, Tokyo, Japan). A stainless steel guide cannula (23-gauge) was implanted chronically into the third cerebroventricle (3vt). This procedure was carried out at least 10 days before the start of infusions. A stainless steel wire stylet (30-gauge) was inserted into the guide cannula to prevent leakage of the CSF and obstruction of the cannula. A stainless steel cannula (23-gauge; 15 mm long) was inserted into the 3vt along the midline 6.0 mm anterior to the zero ear bar coordinate to a depth of 7.8 mm from the cortical surface according to the atlas of Paxinos and Watson (Paxinos and Watson 1986). Similarly, at least 1 week prior to the start of infusions, a cannula was implanted into the lateral cerebroventricle (lvt) of the mice 1.0 mm lateral from the midline and 0.22 mm posterior to the bregma at a depth of 2.0 mm from the cortical surface according to the atlas of Franklin and Paxinos (Franklin and Paxinos 1997). Details of the aforementioned surgical procedures have been described previously (Sakata et al. 1981).
###end p 11
###begin title 12
Drugs
###end title 12
###begin p 13
TRH (10 mumol/mL), pargyline hydrochloride (0.33 mmol/kg), and FMH (50 mg/mL) (Sigma, St Louis, MO, USA) were dissolved in phosphate-buffered saline (PBS). Each solution was prepared freshly on the day of administration. The pH of each solution was adjusted to 6.5-7.5.
###end p 13
###begin title 14
Measurement of food intake
###end title 14
###begin title 15
Change in food intake by different doses of TRH
###end title 15
###begin p 16
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 45 46 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
Rats (n = 24) were divided into four groups (n = 6 per group). Food was removed 24 h before the experiment. On the day of the experiment, TRH (100 nmol/10 muL/10 min), TRH (10 nmol/10 muL/10 min), TRH (1 nmol/10 muL/10 min) or PBS were centrally infused. Food intake was measured for 1 h following the infusion of TRH or PBS.
###end p 16
###begin title 17
Changes in food intake regulated by TRH after histamine depletion
###end title 17
###begin p 18
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 106 107 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
###xml 112 116 <span type="species:ncbi:10116">rats</span>
Rats (n = 24) that were matched on the basis of body mass were allocated to one of four treatment groups (n = 6 rats per group). Food was removed 24 h before the experiment. On the day of the experiment, an equivalent volume of FMH (50 mg/kg) or PBS was administered (i.p.) 1 h before central infusion of TRH (100 nmol/10 muL/10 min) or PBS (10 muL/10 min). Food intake was measured for 1 h following the infusion of TRH or PBS.
###end p 18
###begin title 19
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Changes in food intake regulated by TRH in H1KO mice
###end title 19
###begin p 20
###xml 135 136 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 162 163 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
Food was removed 24 h before the experiment. On the day of the experiment, TRH (10 nmol/muL) or PBS was infused via the lvt into H1KO (n = 12) or wild-type mice (n = 12) at a rate of 1.0 muL/min for 1 min. Food intake was measured for 1 h following the infusion of TRH or PBS.
###end p 20
###begin title 21
Measurement of hypothalamic histamine and tele-methylhistamine content after central infusion of TRH or FMH
###end title 21
###begin p 22
###xml 519 520 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 557 558 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
###xml 513 517 <span type="species:ncbi:10116">rats</span>
Rats were pre-treated with pargyline hydrochloride (0.33 mmol/kg, i.p.), an inhibitor of monoamine oxidase B which induced accumulation of tete-methylhistamine (t-MH) in the extraneural space as a major metabolite of released neuronal histamine 90 min before the central infusion of either TRH (100 nmol/10 muL/10 min), TRH (10 nmol/10 muL/10 min), TRH (1 nmol/10 muL/10 min), or PBS (10 muL/10 min). Different doses of TRH or PBS was infused centrally at a rate of 1 muL/min for 10 min to each group. Additional rats (n = 12) were divided into two groups (n = 6 per group). FMH (50 mg/kg) or PBS was intraperitoneally administered.
###end p 22
###begin p 23
###xml 4 8 <span type="species:ncbi:10116">rats</span>
All rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) before being exsanguinated by transcardiac perfusion with 100 mL saline that contained 200 units of heparin. After decapitation, the brain (including the encephalon) was removed and snap-frozen in liquid nitrogen. Brain regions that contained the lateral hypothalamus, PVN, VMH, and TMN were dissected using a frozen razor blade. The dissected tissue was submerged in 400 muL 0.5 M acetic acid before being homogenized. The homogenate was boiled for 10 min before a 50-muL sample was removed for a protein assay (Bio-Rad Laboratories, Hercules, CA, USA). Histamine content was measured in 50-muL samples using a histamine radioimmunoassay (RIA) kit (Eikenkagaku, Tokyo, Japan). The concentration of t-MH in each sample was measured in a 40-muL sample using a t-MH RIA kit (Pharmacia Upjohn, Tokyo, Japan), except FMH-infused group.
###end p 23
###begin title 24
Measurement of HDC activity in the TMN and t-MH contents in the TMN, anterior hypothalamus and cortex after microinfusion of TRH into the TMN
###end title 24
###begin p 25
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 544 567 544 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Paxinos and Watson 1986</xref>
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
###xml 107 111 <span type="species:ncbi:10116">rats</span>
###xml 140 144 <span type="species:ncbi:10116">rats</span>
###xml 203 207 <span type="species:ncbi:10116">rats</span>
###xml 977 981 <span type="species:ncbi:10116">rats</span>
Rats (n = 24) were used to measure HDC activity and brain t-MH levels following perfusion of TRH or PBS (6 rats per group) and additional 6 rats were used to verify the precise position of infusion. All rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.), placed in stereotaxic apparatus and unilaterally implanted with a stainless steel guide cannula (23-gauge; 15 mm long). TMN coordinates was -4.3 mm from bragma, lateral 1.5 mm to the midbrain, 8.0 mm below the cortical surface, according to the atlas of Paxinos and Watson (Paxinos and Watson 1986). Each guide cannula was placed with its tip 1 mm above its target site (unilateral side). A stainless wire stylet (29 gauge) was placed in the guide cannula until the testing day. A 16-mm-long infusion cannula (29 gauge) was unilaterally inserted into the guide cannula 30 min before testing so that the tip of the infusion cannula protruded 1 mm beyond the tip of the guide cannula. On the testing day, all rats were ascertained to have recovered to at least the pretreatment body weight. TRH (10 nmol/muL) or PBS was infused at the rate of 0.2 muL /min for 5 min (1 muL). Brain was removed and sections containing the TMN, anterior hypothalamus (AH) and cerebral cortex were dissected with a frozen razorblade. After homogenization, the concentration of tele-methylhistamine (t-MH) in each sample was measured using a t-MH RIA kit.
###end p 25
###begin p 26
###xml 44 45 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 275 276 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 318 319 316 317 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 472 473 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
###xml 466 470 <span type="species:ncbi:10116">rats</span>
Rats treated with TRH (10 nmol/muL) or PBS (n = 6 per group) were used to measure the HDC activity in the TMN. HDC activity was evaluated by measuring the formation of histamine from L-histidine in the sample. After homogenization with 400 muL PBS and centrifugation at 1000 g, the reaction was started by addition of l-histidine (0.25 mmol/L) to the sample, incubated for 1 h. Histamine concentration was measured using a histamine RIA kit. Brains of the remaining rats (n = 6) were fixed by 4% paraformaldehyde and cut into 40-mum coronal sections through TMN.
###end p 26
###begin title 27
###xml 26 29 <span type="species:ncbi:10116">rat</span>
Quantitative detection of rat HDC mRNA in the TMN by real-time reverse transcription polymerase chain reaction
###end title 27
###begin p 28
###xml 989 990 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 990 991 962 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 464 467 <span type="species:ncbi:10116">rat</span>
On the testing day, TRH (1 nmol/muL), TRH (10 nmol/muL), TRH (50 nmol) or PBS was infused at the rate of 0.2 muL /min for 5 min (1 muL). Brain was removed and the section containing the TMN was dissected with a frozen razorblade. One-tube RT-PCR was performed using the Qiagen (Valencia, CA, USA) one-tube RT-PCR kit according to manufacturer's recommendations. Primer sets included 5'-CCCAGTGAATACCATGAATAC-3' (sense) and 5'-ATGTCCCCAAAGATGCTA-3' (antisense) for rat HDC determination (designed based on GenBank accession number M29591). RT was performed at 50degreesC for 30 min. followed 40 cycles of PCR (95degreesC 30 s, 55degreesC 30 s, 72degreesC 30 s). Expression of each target gene was normalized to total RNA and samples run in triplicate. The standard curve samples used for RT-PCR were prepared by serial dilution of a RNA sample of known concentration to cover the range of 3000 to 3 ng. The log-linear portion of the standard curve was identified and regression coefficient R2 equaled 1.00. Threshold cycle (Ct) data were used to determine the amount of each target gene in the hypothalamus. DeltaCt was defined as the average Ct value for PBS, TRH (1 nmol), TRH (10 nmol) or TRH (50 nmol) group, respectively. The percent change in expression, relative to the chow group, was defined as 2 -DeltaDeltaCt x 100, where DeltaDeltaCt equals the group DeltaCt minus the DeltaCt of PBS group. The SE of the DeltaDeltaCt is considered the same as the SE of the DeltaCt value because the calculation of DeltaDeltaCt is subtraction of an arbitrary constant.
###end p 28
###begin title 29
Immunohistochemistry
###end title 29
###begin p 30
###xml 705 706 692 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 707 708 694 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
###xml 811 817 <span type="species:ncbi:9913">bovine</span>
###xml 847 851 <span type="species:ncbi:9925">goat</span>
###xml 926 932 <span type="species:ncbi:9986">rabbit</span>
###xml 989 992 <span type="species:ncbi:10116">rat</span>
###xml 1089 1093 <span type="species:ncbi:9925">goat</span>
###xml 1099 1105 <span type="species:ncbi:9986">rabbit</span>
###xml 1269 1275 <span type="species:ncbi:9986">rabbit</span>
###xml 1319 1322 <span type="species:ncbi:10116">rat</span>
###xml 1481 1485 <span type="species:ncbi:9925">goat</span>
###xml 1491 1497 <span type="species:ncbi:9986">rabbit</span>
Rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) before being exsanguinated by transcardiac perfusion with 50 mL saline that contained 50 units of heparin. This was followed by transcardiac perfusion with 300 mL 4% paraformaldehyde in ice-cold PBS. The brain was removed and divided into three segments (forebrain, diencephalon, and brain stem). The diencephalon was stored in PBS overnight. The tissue was then submerged in a 20% sucrose solution for 2 days, followed by submersion in a 30% sucrose solution for 3 days. Thereafter, the tissue was snap-frozen at -80degreesC before being sectioned at a thickness of 30 mum with a cryostat at -20degreesC. Sections were treated with 0.3% H2O2 in PBS for 30 min before being pre-soaked for 1 h in PBS that contained 0.3% Triton X-100 (Sigma), 2% bovine serum albumin, and 2% normal goat serum. The sections were incubated overnight at 4degreesC with polyclonal rabbit antiserum recognizing TRH-R1 or TRH-R2 (specificity for rat, 1 : 500; Santa Cruz Biotechnology Inc., CA, USA), followed by detection with biotin-conjugated goat anti-rabbit IgG and FITC-conjugated streptoavidin (ABC reagent; Vector Laboratories, Burlingame, CA, USA). Sections were then incubated overnight at 4degreesC with polyclonal rabbit antiserum recognizing HDC (specificity for rat, 1 : 2000; Chemicon Inc., Temecula, CA, USA) in a buffer that contained 0.3% Triton X-100 and 1% NGS. Sections were subsequently exposed to biotin-conjugated goat anti-rabbit IgG (ABC reagent; Vector Laboratories) and Rhodamine-conjugated streptoavidin (ABC reagent; Vector Laboratories). Negative control (single staining for HDC) was performed in each experiment, in which one of the primary antibodies (TRH-R1 or TRH-R2) was replaced with the normal serum, and further incubation with both secondary antibodies was performed as usual. Stained sections were examined with a confocal immunofluorescence microscope (Olympus, Tokyo, Japan). The area immunostained by antibodies were analyzed with a computed image analyzer (Lumina Vision, Mitsutani Corp. Kyoto, Japan). Rhodamine-stained area and FITC-stained area were visualized as red and green signals, respectively. The results are computer images of the same section that can be manipulated using reconstruction technique. Images were not adjusted or altered in any way, except for occasional adjustment of brightness.
###end p 30
###begin title 31
Statistics
###end title 31
###begin p 32
###xml 71 76 69 74 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">anova</sc>
###xml 137 145 135 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
###xml 184 185 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Data are expressed as the mean +/- SE. Differences were analyzed using anova followed by Fisher's protected least-significant difference post hoc test. Significance was established at p < 0.05.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
Dose-response of TRH on food intake and contents of histamine and t-MH in the TMN
###end title 34
###begin p 35
###xml 227 228 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 495 502 483 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1a</xref>
The central infusion of TRH at 100 and 500 nmol doses resulted in significant reduction of 1-hr food intake by about 50% (1.80 +/- 0.36 vs. 3.85 +/- 0.45 g and 1.17 +/- 0.17 vs. 3.85 +/- 0.45 g, respectively), compared to PBS (p < 0.05 and 0.01, respectively). Furthermore, TRH at the dose of 10-500 nmol decreased food intake in a dose-dependent manner. However, no significant suppression of 1-hr food intake was observed at 10 nmol of TRH, compared to PBS (3.27 +/- 0.3 vs. 3.85 +/- 0.45 g) (Fig. 1a).
###end p 35
###begin p 36
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 432 433 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 590 591 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 631 632 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 671 672 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 97 101 <span type="species:ncbi:10116">rats</span>
###xml 426 430 <span type="species:ncbi:10116">rats</span>
###xml 554 558 <span type="species:ncbi:10116">rats</span>
Dose effect of TRH on food intake and histamine contents in the TMN. (a) Food intake over 1 h in rats (n = 6 per group) after the central infusion of TRH at 10, 100 or 500 nmol or PBS. *p < 0.05 versus, **p < 0.01 versus PBS and TRH (10 nmol), #p </= 0.05 versus TRH (100 nmol). 3vt infusion of TRH at 100 and 500 nmol elevated the contents of histamine (b) and t-MH (c) in the TMN. (b) Histamine concentrations in the TMN of rats (n = 6 per group) treated by 3vt infusion with PBS or TRH (10, 100, or 500 nmol). (c) Concentrations of t-MH in the TMN of rats treated as described for (c). *p < 0.05 versus PBS and TRH (10 nmol), **p < 0.01 versus PBS and TRH (10 nmol), #p </= 0.05 versus TRH (100 nmol).
###end p 36
###begin p 37
###xml 110 123 110 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1b and c</xref>
###xml 255 268 255 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1b and c</xref>
###xml 482 495 482 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1b and c</xref>
###xml 92 96 <span type="species:ncbi:10116">rats</span>
We also examined the effect of different doses of TRH on histamine metabolism in the TMN of rats. As shown in Fig. 1b and c, the central infusion of TRH at 100 and 500 nmol doses increased histamine and t-MH contents in the TMN but not at 10 nmol of TRH (Fig. 1b and c). Thus, 100 nmol was the minimal effective dose of TRH to suppress feeding and increase histamine turnover in this experiment. Moreover, histamine and t-MH contents were also increased in a dose-dependent manner (Fig. 1b and c).
###end p 37
###begin title 38
Histamine content in the TMN after the FMH administration
###end title 38
###begin p 39
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 125 131 125 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2</xref>
###xml 108 112 <span type="species:ncbi:10116">rats</span>
###xml 224 227 <span type="species:ncbi:10116">rat</span>
Histamine content in the TMN after the administration of FMH (50 mg/kg) was significantly reduced by 73% in rats (p < 0.05) (Fig. 2). Therefore, FMH at 50 mg/kg dose is enough to deplete neuronal histamine in the TMN of the rat hypothalamus.
###end p 39
###begin p 40
###xml 217 218 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Effect of alpha-fluoromethylhistidine (FMH; 50 mg/kg, i.p.) on hypothalamic histamine content in the 2 h after the administration. The i.p. administration of FMH decreased histamine content in the TMN significantly. *p < 0.05 versus PBS.
###end p 40
###begin title 41
###xml 65 69 <span type="species:ncbi:10116">rats</span>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Attenuation of the anorexic effects of TRH in histamine-depleted rats and H1KO mice
###end title 41
###begin p 42
###xml 155 156 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 223 224 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 417 418 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 524 531 518 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3a</xref>
###xml 616 617 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 723 724 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 759 766 753 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3b</xref>
###xml 15 19 <span type="species:ncbi:10116">rats</span>
###xml 200 204 <span type="species:ncbi:10116">rats</span>
###xml 439 443 <span type="species:ncbi:10116">rats</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
Food intake in rats whose hypothalamic histamine content was increased by bolus administration of TRH (100 nmol) into the 3vt (1.34 +/- 0.43 g) was lower (p < 0.01) than that in control (PBS-treated) rats (4.14 +/- 0.29 g; n = 6 per group). This anorexic effect of TRH was significantly attenuated by pretreatment with FMH, which was associated with a significantly smaller reduction in food intake (2.34 +/- 0.16 g; p < 0.05) compared to rats treated with TRH alone. Administration of FMH alone did not affect food intake (Fig. 3a). Similarly, TRH caused a 50% reduction in food intake in control (wild-type) mice (p < 0.01), whereas the same treatment of histamine-depleted H1KO mice caused a significantly smaller (30%; p < 0.05) reduction in food intake (Fig. 3b).
###end p 42
###begin p 43
###xml 242 243 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 391 392 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 454 467 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 467 468 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 540 541 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 637 638 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 692 705 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 705 706 677 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 755 767 727 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 767 768 728 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 73 77 <span type="species:ncbi:10116">rats</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10116">rats</span>
###xml 495 499 <span type="species:ncbi:10116">rats</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
Anorexia induced by thyrotropin-releasing hormone (TRH) is attenuated in rats pre-treated with alpha-fluoromethylhistidine (FMH) and in mice with targeted disruption of the histamine H1 receptor (H1KO mice). (a) Food intake over 1 h in rats (n = 6 per group) treated with PBS (third cerebroventricle (3vt) infusion), FMH (50 mg/kg, i.p.), TRH (100 nmol; 3vt infusion), or both FMH and TRH. *p < 0.01 versus PBS-treated controls and FMH-treated controls. double daggerp < 0.05 versus TRH-treated rats. (b) Food intake over 1 h in H1KO mice (n = 6 per group) treated with PBS (lateral ventricle infusion) or TRH (100 nmol; lvt infusion). *p < 0.05 versus PBS-treated controls (wild-type mice). double daggerp < 0.05 versus PBS-treated controls (H1KO mice). section signp < 0.05 versus TRH-treated wild-type mice.
###end p 43
###begin title 44
Effects of TRH on hypothalamic histamine and t-MH content
###end title 44
###begin p 45
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 102 109 102 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4a</xref>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 227 234 227 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4b</xref>
###xml 196 200 <span type="species:ncbi:10116">rats</span>
Central infusion of TRH increased the concentration of histamine in the TMN (p < 0.01 versus control; Fig. 4a) and increased the pargyline-induced accumulation of t-MH in the TMN, VMH, and PVN in rats (p < 0.05 versus control; Fig. 4b).
###end p 45
###begin p 46
###xml 364 365 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 526 527 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 358 362 <span type="species:ncbi:10116">rats</span>
###xml 490 494 <span type="species:ncbi:10116">rats</span>
Effects of TRH on hypothalamic histamine and telemethylhistamine (t-MH) content. 3vt infusion of TRH elevated the concentration of histamine within the tuberomammillary nucleus (TMN) (a) and increased the concentration of t-MH in the TMN, paraventricular nucleus, and ventromedial hypothalamus (b). (a) Histamine concentrations in the hypothalamic nuclei of rats (n = 6 per group) treated by 3vt infusion with PBS or TRH (100 nmol). (b) Concentrations of t-MH in the hypothalamic nuclei of rats treated as described for (a). *p < 0.05 versus PBS-treated controls.
###end p 46
###begin title 47
Effect of TRH administration into the TMN on t-MH contents, HDC activity and HDC mRNA expression in the TMN
###end title 47
###begin p 48
###xml 74 81 74 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5a</xref>
###xml 84 107 84 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Paxinos and Watson 1986</xref>
###xml 110 117 110 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5b</xref>
###xml 571 572 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 581 588 581 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6a</xref>
###xml 700 701 700 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 710 717 710 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6b</xref>
###xml 937 944 937 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6c</xref>
###xml 154 158 <span type="species:ncbi:10116">rats</span>
Placement of the cannula was compared to the atlas of Paxinos and Watson (Fig. 5a) (Paxinos and Watson 1986). Fig. 5b shows a typical TRH-infused site in rats. It was verified that the tip of guide cannula was just above the TMN. No chronically implanted guide cannula was found to touch or damage the tissue of a target locus. The insertion of the thin infusion cannula did not cause excessive tissue destruction. Microinfusion of TRH into the TMN increased the t-MH content in TMN of the hypothalamus, but not in the AH and cerebral cortex, compared with PBS infusion (p < 0.05; Fig. 6a). Correspondingly, the activity of HDC was also increased by administration of TRH compared with PBS infusion (p < 0.05; Fig. 6b). Moreover, HDC expression was increased by microinfusion of TRH at 10 and 50 nmol into the TMN but not at 1 nmol dose of TRH. Moreover, TRH at the dose of 1-50 nmol increased HDC expression in a dose-dependent manner (Fig. 6c).
###end p 48
###begin p 49
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 431 432 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 560 561 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 610 611 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Effects of TRH injection into the TMN of the hypothalamus on tele-methylhistamine (t-MH) contents, HDC activity and HDC mRNA expression in the TMN. (a) Microinfusion of TRH (10 nmol) into the TMN of the hypothalamus elevated the t-MH contents in the TMN, but not in the AH and cerebral cortex. *p < 0.05 versus PBS-treated controls. (b) Microinfusion of TRH (10 nmol) into the TMN significantly increased HDC activity in the TMN. *p < 0.05 versus PBS infusion. (c) Expression of HDC in the TMN of TRH (1, 10, or 50 nmol) and PBS groups with real-time RT-PCR. *p </= 0.05 versus PBS and TRH (1 nmol) infusion, #p </= 0.05 versus TRH (10 nmol) infusion.
###end p 49
###begin p 50
Schema indicating the area of TMN in the hypothalamus and histological identification of cannula tips in a representative infusion site stained by histamine neurons. TMN, tuberomammillary nucleus; D3 V, dorsal third ventricle; LV, lateral ventricle; MRe, mammillary recess of third ventricle. Tip of cannula was just above the TMN. Scale bar: 200 mum.
###end p 50
###begin title 51
Immunohistochemical detection TRH-R1 and TRH-R2 in histaminergic neurons
###end title 51
###begin p 52
###xml 136 143 136 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7a</xref>
###xml 246 253 246 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7b</xref>
###xml 348 355 348 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7c</xref>
###xml 110 114 <span type="species:ncbi:10116">rats</span>
Specific antibodies revealed that TRH-R2 (green) was expressed within histaminergic cell bodies in the TMN of rats (red, white arrows) (Fig. 7a), whereas there was no expression of TRH-R1 (green) in histaminergic cell bodies (red, white arrows) (Fig. 7b). The specificity of the labeling was controlled by omitting the TRH-R1 or TRH-R2 antiserum. (Fig. 7c).
###end p 52
###begin p 53
Immunohistochemical detection of TRH receptors in histaminergic neurons within the TMN. (a) Histaminergic neurons (red, white arrows) expressed TRH type 2 receptors (green). (b) Histaminergic neurons (red, white arrows) did not express TRH type 1 receptors (green). (c) Substitution of TRH-R1 or TRH-R2 antibodies with normal serum and incubation with secondary antibody as for double staining results in no detectable signal. Scale bar: 10 mum.
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 303 321 303 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">Suzuki <italic>et al.</italic> 1982</xref>
###xml 743 749 743 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 736 754 736 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">Oohara <italic>et al.</italic> 1994</xref>
###xml 303 309 <span type="species:ncbi:8164">Suzuki</span>
###xml 854 858 <span type="species:ncbi:10090">mice</span>
The present study demonstrated that the central infusion of TRH at 100 nmol not but 10 nmol induced suppression of food intake. This finding is consistent with the previous study showing that the central infusion of TRH (25, 50, 100 nmol) suppressed starvation-induced feeding in a dose related manner (Suzuki et al. 1982). Moreover, the depletion of neuronal histamine by pre-treatment with FMH attenuated TRH-induced suppression of food intake. These results suggest that endogenous neuronal histamine may mediate the suppression of food intake by TRH. We showed previously that hypothalamic neuronal histamine suppressed food intake via H1 receptors within the VMH and PVN, both of which are nuclei that are central to satietiation (Oohara et al. 1994). Our finding in the present study that the anorexigenic effect of TRH was also attenuated in H1KO mice is further evidence that histamine and H1 receptors mediate TRH signaling to suppress food intake.
###end p 55
###begin p 56
The involvement of TRH-histamine signaling in suppressing food intake was also demonstrated by our study that hypothalamic histamine and t-MH concentrations exhibited region-specific increased in response to the administration of TRH and this effect of TRH was dose-dependent in the range of 10 to 500 nmol. Specifically, the increase in histamine concentrations was restricted to the TMN and was not detected in any other hypothalamic nuclei. After pretreatment with pargyline hydrochloride, infusion of TRH into the 3vt increased the concentration of t-MH not only in the TMN but also in the PVN and VMH, which indicated that TRH induced an increase in histamine turnover within these nuclei.
###end p 56
###begin p 57
###xml 377 383 377 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 370 388 370 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">Oohara <italic>et al.</italic> 1994</xref>
It might be suggested TRH infusion did not affect concentration of hypothalamic histamine in the hypothalamic nucleus except the TMN because histamine levels measured in present study included released histamine in the extraneuronal space as well as intracellular histamine in the nerve terminal and histamine is rapidly converted to its metabolite, t-MH, in the brain (Oohara et al. 1994).
###end p 57
###begin p 58
###xml 598 604 598 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 592 609 592 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Oishi <italic>et al.</italic> 1987</xref>
###xml 618 624 618 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 611 629 611 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">Oohara <italic>et al.</italic> 1994</xref>
Moreover, microinfusion of TRH into the TMN increased HDC activity and t-MH content in the TMN. The transmethylation of histamine into t-MH, a major metabolite of histamine, and its subsequent deamination, is the major metabolic pathway of histamine in the brain. Therefore, it is much more informative to analyze histamine release by measuring its metabolite than to rely on a measurement of the brain histamine level itself. Pre-treatment with pargyline, an inhibitor of monoamine oxidase B, is useful for this assessment, as it induces the accumulation of t-MH in the extraneuronal space (Oishi et al. 1987; Oohara et al. 1994, 1994).
###end p 58
###begin p 59
###xml 124 150 124 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">Sakata and Yoshimatsu 1997</xref>
The TMN contains the cell bodies of histaminergic neurons, whereas the PVN and VMH are major projection sites of histamine (Sakata and Yoshimatsu 1997). Based on this anatomical scheme, we conclude that TRH increased histamine turnover not only in cell bodies within the TMN but also at the nerve terminals within the PVN and VMH. The possibility that TRH directly modulated histamine release at nerve terminals in these sites cannot be excluded; however, it is likely that TRH activates histaminergic neurons within the TMN, and thereafter induces histamine release from the nerve terminals at projection sites because TRH receptors are expressed on the cell bodies of histaminergic neurons within the TMN.
###end p 59
###begin p 60
###xml 612 618 612 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 601 623 601 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">Airaksinen <italic>et al.</italic> 1992</xref>
###xml 862 868 862 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 855 873 855 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">Mignot <italic>et al.</italic> 2002</xref>
###xml 881 887 881 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 875 892 875 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Huang <italic>et al.</italic> 2007</xref>
TRH-R1 and TRH-R2 exhibit distinct expression patterns within the brain. In general, TRH-R1 is localized to the hypothalamus and brain stem, which supports a link between TRH-R1 and vegetative and autonomic functions. In contrast, TRH-R2 mRNA is distributed widely throughout the brain, including the cerebral cortex and reticular formation, which indicates that TRH-R2 may be involved in regulating cognition and the arousal system. In the present study, we identified TRH-R2, but not TRH-R1, within the cell bodies of histaminergic neurons within the TMN. TRH-containing neurons project to the TMN (Airaksinen et al. 1992), and it is well established that hypothalamic neuronal histamine regulates the sleep-wake cycle via connections to the ventrolateral preoptic area (the "sleep center") and orexinergic neurons within the lateral hypothalamic area (Mignot et al. 2002; Huang et al. 2007). Therefore, the TRH-TRH-R2-histamine pathway may constitute a neuronal network that regulates arousal. In addition, our findings suggest that this pathway also contributes to the effects of TRH on feeding behavior.
###end p 60
###begin p 61
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 292 312 292 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Ishizuka <italic>et al.</italic> 2006</xref>
Present study suggests that both orexin and TRH may be able to stimulate histaminergic system. Orexin increases food intake whereas TRH decreases it. Previous study reported that the central administration of orexin-A caused a significant increase in locomotor activity, but not food intake (Ishizuka et al. 2006). From these findings, it may be concluded that the histaminergic system participates in arousal state rather than feeding regulation by orexinergic neurons. On the other hand, histaminergic system mediates the TRH-induced suppression of feeding behavior partially. The mechanism involved in the anorectic effect of TRH except histaminergic system is uncertain, but it is possibility that TRH might cause anorectic effect by activating TRH receptors localized in the PVN and VMH, regions known to be involved in control of food intake and the site of the so-called satiety center, directly.
###end p 61
###begin p 62
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 49 70 49 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Campfield <italic>et al.</italic> 1995</xref>
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 131 153 131 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">Yoshimatsu <italic>et al.</italic> 2001</xref>
###xml 361 367 361 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 381 387 381 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 374 392 374 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Masaki <italic>et al.</italic> 2001</xref>
###xml 696 724 696 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Flier and Maratos-Flier 1998</xref>
###xml 726 740 726 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">Mantzoros 1999</xref>
###xml 749 755 749 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 742 760 742 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">Nillni <italic>et al.</italic> 2000</xref>
###xml 955 961 955 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 949 966 949 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">Gotoh <italic>et al.</italic> 2005</xref>
###xml 1157 1185 1157 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Flier and Maratos-Flier 1998</xref>
###xml 1187 1201 1187 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">Mantzoros 1999</xref>
###xml 1210 1216 1210 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1203 1221 1203 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">Nillni <italic>et al.</italic> 2000</xref>
###xml 232 236 <span type="species:ncbi:10116">rats</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 374 380 <span type="species:ncbi:212708">Masaki</span>
Leptin acts on the brain to inhibit food intake (Campfield et al. 1995). 3vt infusion of leptin increases histamine turnover rate (Yoshimatsu et al. 2001). Leptin-induced suppression of feeding was reported to be attenuated both in rats whose histamine was depleted by FMH, a suicide inhibitor of histamine synthesizing HDC enzyme, and in H1KO mice (Yoshimatsu et al. 1998; Masaki et al. 2001). Despite these findings, how leptin activates histamine-containing neurons within the hypothalamus is not known. Leptin receptor mRNA is expressed within the PVN (which is where the cell bodies of neurons that release TRH are located) but not in the TMN (which is the origin of histaminergic neurons) (Flier and Maratos-Flier 1998; Mantzoros 1999; Nillni et al. 2000). Recently, we reported that neurons that contain glucagon-like peptide 1 (GLP-1) and corticotropin-releasing hormone may mediate leptin signaling to histaminergic neurons within the TMN (Gotoh et al. 2005). The results of the present study suggest that there is an additional pathway that transmits leptin signals to the histaminergic system. Because leptin increases TRH expression in the PVN (Flier and Maratos-Flier 1998; Mantzoros 1999; Nillni et al. 2000), and in light of our finding a functional and neuroanatomical link between TRH and neuronal histamine, it is likely that leptin may activate histaminergic neurons indirectly via neurons that release TRH.
###end p 62
###begin title 63
Abbreviations used
###end title 63
###begin p 64
thyrotropin-releasing hormone
###end p 64
###begin p 65
third cerebroventricle
###end p 65
###begin p 66
tuberomammillary nucleus
###end p 66
###begin p 67
histidine decarboxylase
###end p 67
###begin p 68
ventromedial hypothalamus
###end p 68
###begin p 69
paraventricular nucleus
###end p 69
###begin p 70
alpha-fluoromethylhistidine
###end p 70
###begin p 71
phosphate-buffered saline
###end p 71
###begin p 72
radioimmunoassay
###end p 72
###begin p 73
This study was supported by a grant from the Japanese Ministry of Health for regulating energy metabolism.
###end p 73
###begin title 74
References
###end title 74
###begin article-title 75
Role of leptin in the neuroendocrine response to fasting
###end article-title 75
###begin article-title 76
###xml 74 77 <span type="species:ncbi:10116">rat</span>
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
###xml 90 100 <span type="species:ncbi:10141">guinea pig</span>
Multiple neurotransmitters in the tuberomammillary nucleus: comparison of rat, mouse, and guinea pig
###end article-title 76
###begin article-title 77
Effects of TRH on central nervous system function
###end article-title 77
###begin article-title 78
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks
###end article-title 78
###begin article-title 79
###xml 62 66 <span type="species:ncbi:10116">rats</span>
Hypothalamic neuronal histamine regulates circadian rhythm in rats
###end article-title 79
###begin article-title 80
###xml 54 57 <span type="species:ncbi:10116">rat</span>
Distributions of leptin receptor mRNA isoforms in the rat brain
###end article-title 80
###begin article-title 81
Obesity and the hypothalamus: novel peptides for new pathways
###end article-title 81
###begin article-title 82
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Neuronal histamine modulates feeding behavior through H1 receptors in rat hypothalamus
###end article-title 82
###begin article-title 83
Glucagon-like peptide-1, corticotropin-releasing hormone, and hypothalamic neuronal histamine interact in the leptin-signaling pathway to regulate feeding behavior
###end article-title 83
###begin article-title 84
Arousal effect of orexin A depends on activation of the histaminergic system
###end article-title 84
###begin article-title 85
###xml 124 128 <span type="species:ncbi:10090">mice</span>
Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice
###end article-title 85
###begin article-title 86
Prostaglandins and adenosine in the regulation of sleep and wakefulness
###end article-title 86
###begin article-title 87
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors
###end article-title 87
###begin article-title 88
A role of the histaminergic system for the control of feeding by orexigenic peptides
###end article-title 88
###begin article-title 89
Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus
###end article-title 89
###begin article-title 90
Leptin and the hypothalamus: neuroendocrine regulation of food intake
###end article-title 90
###begin article-title 91
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Targeted disruption of histamine H1 receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice
###end article-title 91
###begin article-title 92
Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders
###end article-title 92
###begin article-title 93
Thyrotropin releasing hormone (TRH) suppresses stress induced eating
###end article-title 93
###begin article-title 94
The biology of pro-thyrotropin-releasing hormone-derived peptides
###end article-title 94
###begin article-title 95
Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways
###end article-title 95
###begin article-title 96
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
###xml 80 83 <span type="species:ncbi:10116">rat</span>
Feeding-related circadian variation in tele-methylhistamine levels of mouse and rat brains
###end article-title 96
###begin article-title 97
###xml 68 72 <span type="species:ncbi:10116">rats</span>
Neuronal glucoprivation enhances hypothalamic histamine turnover in rats
###end article-title 97
###begin article-title 98
###xml 67 71 <span type="species:ncbi:10116">rats</span>
Hunger and satiety related activity induced certain metabolites in rats
###end article-title 98
###begin article-title 99
Hypothalamic neuronal histamine: implication of homeostatic maintenance in its control of energy metabolism
###end article-title 99
###begin article-title 100
###xml 64 67 <span type="species:ncbi:10116">rat</span>
Feeding and hyperglycemia induced by 1,5-anhydroglucitol in the rat
###end article-title 100
###begin article-title 101
###xml 56 60 <span type="species:ncbi:10116">rats</span>
Thermoregulation modulated by hypothalamic histamine in rats
###end article-title 101
###begin article-title 102
###xml 116 120 <span type="species:ncbi:10116">rats</span>
Intracranial injection of thyrotropin-releasing hormone (TRH) suppresses starvation-induced feeding and drinking in rats
###end article-title 102
###begin article-title 103
Effects of thyrotropin-releasing hormone on locomotor activity, operant performance and ingestive behavior
###end article-title 103
###begin article-title 104
On the neuropharmacology of thyrotropin releasing hormone (TRH)
###end article-title 104
###begin article-title 105
###xml 32 34 32 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</italic>
###xml 54 57 <span type="species:ncbi:10116">rat</span>
Histamine neurons down-regulate ob gene expression in rat white adipose tissue
###end article-title 105

